Sector News

Medtronic names Mark Ploof SVP of Global Operations and Business Services

September 17, 2016
Life sciences

Medtronic today announced the appointment of Mark Ploof as Senior Vice President, Global Operations and Business Services effective October 31, 2016.

He will serve on the company’s Executive Committee and be responsible for leading Medtronic’s Global Operations, Information Technology, Facilities & Real Estate and Medtronic Business Services functions, which include the company’s ongoing Covidien acquisition integration efforts.

Ploof succeeds Gary Ellis who previously announced plans to retire from the company later this fiscal year after a 27-year Medtronic career. As part of a planned succession, Ellis will remain on the Medtronic Executive Committee and work with Ploof to ensure a smooth transition.

“Mark brings a diverse range of experiences to the Medtronic leadership team as well as a relentless focus on creating operational excellence, value creation and business growth,” said Omar Ishrak, Medtronic Chairman and CEO. “It is an exciting and transformational time for Medtronic, and I am confident in Mark’s ability to help us deliver against our strategic business priorities. From his broad knowledge of operations to his expertise in assessing and identifying opportunities to operate at scale and generate margin expansion, Mark’s vast experiences in a multitude of industries will bring fresh thinking and leadership to our organization.”

“I’m excited for this opportunity with Medtronic and to play such a vital role in helping the company achieve its Mission around the world,” said Ploof. “I am particularly pleased to join the men and women of Medtronic in these functional areas who are driving world class business performance and efficiencies in their work, and I know that we will play an instrumental part in helping Medtronic realize its operational and financial goals in the coming years.”

Ploof worked with Cerberus Capital Management portfolio companies to drive margin expansion, efficiency and value creation efforts in a variety of operations, industries and roles. He brings a track record of assessing, diagnosing and remediating opportunities to capture value and institute new operational and service delivery models to operate efficiently at scale. His business development background at GE and Cerberus companies included creating and executing company integration plans and programs, including facility and supply chain consolidations, shared services and centers of excellence creation and organizational development and alignment efforts.

Ploof joins Medtronic from YP, LLC where he most recently served as the Chief Customer Experience Officer. As a member of YP’s Operating Leadership Team, Ploof oversaw centralized and field service management, quality and operational enablement, and business intelligence. He also served as the company’s Chief Restructuring Officer, focused on YP’s spin-off from AT&T. Under his leadership, YP established and drove significant shareholder returns and significantly improved customer engagement and satisfaction scores.

Ploof has also held senior leadership roles in finance, supply chain, business development and sourcing in Cerberus portfolio companies and at General Electric, where he established a track record of establishing large scale operating models that generated meaningful efficiencies and value creation. Ploof holds a bachelor of business administration degree in Management from Pace University.

Source: Medtronic

comments closed

Related News

October 2, 2022

GSK names Julie Brown, a 25-year AstraZeneca veteran, its first woman CFO

Life sciences

Five years ago, GSK made headlines when it hired Emma Walmsley to become the first woman to run a major pharmaceutical company. Now the Big Pharma has brought in another woman to control the company’s finances. Julie Brown will be GSK’s next chief financial officer. Brown, currently the chief operating and financial officer at fashion and beauty brand Burberry Group, is set to replace Iain Mackay.

October 2, 2022

Moderna creates new launch preparation role, poaches Novartis exec as manufacturing lead

Life sciences

Moderna created a new role responsible for “building out the company’s organization to support its growing pipeline.” Starting first thing 2023, Juan Andres, Moderna’s manufacturing head, will step into this new role under the title president of strategic partnerships and enterprise expansion, the company said Thursday.

October 2, 2022

Torrent Pharma to acquire Curatio for $245.16m

Life sciences

The latest takeover is anticipated to boost the presence of Torrent in the dermatology segment. Indian company Torrent Pharmaceuticals has signed a definitive agreement for the complete acquisition of Curatio Healthcare for $245.16m (Rs20bn).